Related references
Note: Only part of the references are listed.FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival
L. M. Gjerdrum et al.
LEUKEMIA (2007)
Differential expression of TRAH aids in the distinction of cutaneous CD30-positive lymphoproliferations
Chalid Assaf et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
Anders Woetmann et al.
BLOOD (2007)
Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides
Christian Hallermann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Natural regulatory T cells: mechanisms of suppression
Makoto Miyara et al.
TRENDS IN MOLECULAR MEDICINE (2007)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
T. Krejsgaard et al.
LEUKEMIA (2006)
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
Monika Kasprzycka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas
C-D Klemke et al.
LEUKEMIA (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Pathobiology of CD30+ cutaneous T-cell lymphomas
ME Kadin
JOURNAL OF CUTANEOUS PATHOLOGY (2006)
CD4(+)CD25(high) regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers
Koji Kono et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
G Roncador et al.
LEUKEMIA (2005)
Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin
LE Clarke et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies -: Possible involvement of regulatory T cells in disease progression
T Sasada et al.
CANCER (2003)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
Share Paper
